LUMIGAN

*Raised intra-ocular pressure in open-angle glaucoma, Ocular hypertension, as monotherapy or as an adjunct to beta-blockers:* Adult: Apply once daily, to be administered preferably in the evening.

Angle-closure glaucoma, aphakia, asthma, chronic obstructive pulmonary disease, compromised respiratory function, congenital glaucoma, contact lens wearers, history of significant ocular viral infections, inflammatory ocular conditions, narrow-angle glaucoma, neovascular glaucoma, predisposition to bradycardia, predisposition to hypotension, pseudophakia with torn, posterior lens capsule or anterior chamber lenses, risk factors for cystoid macular oedema, iritis or uveitis, renal or hepatic impairment. Monitor for keratopathy in patients with dry eyes.

Headache, ocular discomfort, blood pressure changes, blepharitis, brown pigmentation particularly in those with mixed-colour irides, conjunctival disorders, corneal erosion, darkening, thickening and lengthening of eye lashes, eyelash and vellus hair changes, photophobia, pigmentation of periocular skin, punctate keratitis, reduced visual acuity, transient punctate epithelial erosion